Hepatitis C Same-Day Treatment

Uses

How it works

Benefits

Risks & contraindications

Highlighted claims

• The protocol tests whether same-day presumptive hepatitis C treatment can simplify care for people who inject drugs in low- and middle-income countries. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol
• Arm 2 uses a 5-minute OraQuick antibody result as the preliminary basis for presumptive treatment. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol
• The main risk of the same-day pathway is initiating treatment before RNA and full laboratory safety results are known. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol
• Same-day treatment starts before RNA results are available, and treatment is later continued or stopped based on RNA confirmation. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol
• The study aims to determine whether same-day initiation improves treatment uptake and cure compared with simplified care. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol